Trimegah Bangun Persada Tbk. vs Prodia Widyahusada Tbk. — how do they compare? Trimegah Bangun Persada Tbk. trades at Rp940 (market cap 60.26T, 66.68M 24h volume), while Prodia Widyahusada Tbk. trades at Rp2,810 (market cap 2.63T, 861.1K 24h volume). The key difference: Trimegah Bangun Persada Tbk. is far larger — about 22.9× Prodia Widyahusada Tbk.'s market cap, and Trimegah Bangun Persada Tbk. is more actively traded (66.68M versus 861.1K). Which is the better fit depends on your goals.
| NCKL | PRDA | |
|---|---|---|
Market Cap | 60.26T | 2.63T |
Volume | 66.68M | 861.1K |
Lot | 666.76K | 8.61K |
Turnover | 62.63B | 2.42B |
Average Price | 939.35 | 2,806.54 |
Value | 62.63B | 2.42B |
Indicative Equilibrium Price | 940 | 2,810 |
Indicative Equilibrium Volume | 13.51K | 713 |
Trailing returns across standard periods
Latest headlines on both assets
PT Trimegah Bangun Persada Tbk. (the Company) was established in Indonesia based on Notarial Deed of Erna Priyono, S.H., No. 03 dated September 6, 2004.
Read more on NCKL →PT Prodia Widyahusada Tbk (the Company) was established based on the Deed of Notary Sri Rahayu, SH, No. 14 dated February 8, 1988. Clinical Laboratory Prodia was first established in Solo, Central Java, on May 7, 1973 by a few idealists pharmaceutical educational background.
Read more on PRDA →